Results 201 to 210 of about 205,027 (361)

Outcomes After Switching to Faricimab in Neovascular Age‐Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background We aimed to describe 1‐year outcomes of eyes switched to faricimab from first‐generation vascular endothelial growth factor (VEGF) inhibitors for neovascular age‐related macular degeneration (nAMD) in routine care. Methods Multicentre, observational study of 383 eyes tracked in the Fight Retinal Blindness!
Adrian Hunt, Yohei Hashimoto, Stephanie Young, Jennifer Arnold, Justin Game, Claire Hooper, Andrew Field, Richard Barry, Daniel Barthelmes, Mark Gillies   +9 more
wiley   +1 more source

Ocular perfusion and age‐related macular degeneration [PDF]

, 2001
Thomas A. Ciulla, Alon Harris, Bruce Martin   +2 more
openalex   +1 more source

Retinal Viral Gene Therapy: Impact of Route of Administration on Serious Adverse Events—A Systematic Review

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To explore the prevalence of serious adverse events (SAEs) associated with retinal viral gene therapy and to examine trends influencing SAE occurrences in human gene therapy surgeries and pre‐clinical animal trials. Methods Literature review was performed to identify peer‐reviewed human and animal studies relevant to viral gene ...
Aubrey Berger, Ciera D. Johnson, Alan D. Marmorstein, Brittni A. Scruggs   +3 more
wiley   +1 more source

Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration [PDF]

, 2001
J. Li
openalex   +1 more source

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

A M A Archives of Ophthalmology, 2001
A. Kassoff, J. Kassoff, J. Buehler, M. Eglow, F. Kaufman, M. Mehu, S. Kieval, M. Mairs, B. Graig, A. Quattrocchi, David R. Jones, J. Locatelli, A. Ruby, A. Capon, B. Garretson, T. Hassan, M. Trese, George A. Williams, V. Regan, P. Manatrey, P. Streasick, L. Szydlowski, F. McIver, C. Bridges, C. Stanley, K. Cumming, B. Lewis, M. Zajechowski, R. Margherio, M. Cox, J. Werner, R. Falk, P. Siedlak, C. Neubert, M. Klein, J. T. Stout, A. O'Malley, A. Lauer, J. Robertson, David J. Wilson, C. Beardsley, H. Anderson, P. Wallace, G. Smith, S. Howard, R. Dreyer, C. Ma, R. G. Chenoweth, J. Zilis, M. Johnson, P. Rice, H. Daniel, H. Crider, S. Parker, K. Sherman, Daniel F. Martin, T. Aaberg, P. Sternberg, L. T. Curtis, B. Ju, J. Gilman, B. Myles, S. Strittman, C. Gentry, H. Yi, A. Capone, M. Lambert, T. Meredith, T. Aaberg, D. Saperstein, Jennifer I. Lim, B. Stribling, D. Armiger, R. Swords, D. Orth, T. Flood, J. Civantos, S. deBustros, K. Packo, P. Merrill, J. Cohen, C. Figliulo, C. Morrison, D. Bryant, D. Doherty, M. McVicker, T. Drefcinski, J. Seddon, M. Pinnolis, N. Davis, I. Burton, T. Taitsel, D. Walsh, J. Dubois-Moran, C. Callahan, C. Evans, K. K. Snow, D. A. Jones-Devonish, V. Crouse   +98 more
semanticscholar   +1 more source

New developments in age-related macular degeneration

Community Eye Health Journal, 2008
The World Health Organization (WHO) estimates that over 3 million people (9% of global blindness) are blinded by age-related macular degeneration (AMD). AMD affects people over the age of 55. There are two main types of AMD, dry and wet.
Lyndon da Cruz
doaj  

Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration [PDF]

, 2001
Fumihiko Mori
openalex   +1 more source

Deep Learning‐Based Detection of Reticular Pseudodrusen in Age‐Related Macular Degeneration

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Reticular pseudodrusen (RPD) signify a critical phenotype driving vision loss in age‐related macular degeneration (AMD). This study sought to develop and externally test a deep learning (DL) model to detect RPD on optical coherence tomography (OCT) scans with expert‐level performance.
Himeesh Kumar, Yelena Bagdasarova, Scott Song, Doron G. Hickey, Amy C. Cohn, Mali Okada, Robert P. Finger, Jan H. Terheyden, Ruth E. Hogg, Pierre‐Henry Gabrielle, Louis Arnould, Maxime Jannaud, Xavier Hadoux, Peter van Wijngaarden, Carla J. Abbott, Lauren A. B. Hodgson, Roy Schwartz, Adnan Tufail, Emily Y. Chew, Cecilia S. Lee, Erica L. Fletcher, Melanie Bahlo, Brendan R. E. Ansell, Alice Pébay, Robyn H. Guymer, Aaron Y. Lee, Zhichao Wu   +26 more
wiley   +1 more source

Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear [PDF]

, 2001
B. A. Lafaut
openalex   +1 more source

Ten‐Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age‐Related Macular Degeneration

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To evaluate the 10‐year cumulative incidence, progression rates, and risk factors for macular atrophy (MA) in neovascular age‐related macular degeneration (nAMD) patients receiving long‐term anti‐vascular endothelial growth factor (VEGF) therapy.
Francesco Romano, Marco Casaluci, Antonio Valastro, Matteo Airaldi, Paolo Milella, Francesco Pozzo Giuffrida, Elisa Cozzi, Andrea Aretti, Kelvin YC Teo, Chui Ming Gemmy Cheung, Marco Nassisi, Francesco Viola, Giovanni Staurenghi, Alessandro Invernizzi   +13 more
wiley   +1 more source